Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial (Q41927602)
Jump to navigation
Jump to search
scientific article published on 29 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial |
scientific article published on 29 November 2012 |
Statements
1 reference
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial (English)
1 reference
Johan A Karlsson
1 reference
Martin Neovius
1 reference
Jan-Åke Nilsson
1 reference
Ingemar F Petersson
1 reference
Johan Bratt
1 reference
Sofia Ernestam
1 reference
Pierre Geborek
1 reference
29 November 2012
1 reference
1 reference
72
1 reference
12
1 reference
1927-1933
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference